News

The survey identified long-term health complications of sickle cell disease as a primary concern among patients and providers and overall understanding of the disease needs more educational support.

The prevalence rate of VTE was 2% among a large population of SCD patients in Nigeria.

There is not much known on the link between sickle cell disease and romantic relationships, particularly from the male perspective.

Dr. Temeia Martin talks about how her team identified the transition period as a major obstacle for patients with sickle cell disease and what her task force has implemented as a solution.

The FDA amended the EUA to include the use of Moderna in individuals 6 months through 17 years of age and Pfizer in those 6 months through 4 years of age.

The approval represents the first and only specific interleukin-23 (IL-23) inhibitor for this patient population.

An increased risk of obesity and decreased risk of abnormal weight loss was also observed in patients born to mothers with sickle cell disease.

With World Sickle Cell Day approaching, Dr. Titi Fasipe reflects on the developments within the field, such as the continued conversation of disparities and the increased comfort level with new therapies.

In the Archway trial, 93.2% of patients preferred treatment with ranibizumab delivered via the PDS compared to only 1.3% of patients who preferred intravitreal injections.

Azathioprine and 6-mercaptopurine therapeutic drug monitoring informed a management change in 61.9% of the patients with IBD.

Investigators confirmed olanzapine and samidorphan (LYBALVI) resulted in statistically significant less weight gain compared to patients with schizophrenia between 16-39 years treated with olanzapine.

Investigators suggested that antipruritic therapies be offered to patients with psoriasis, as most psoriasis therapies did not result in any improvements.

Acute hepatitis of unknown etiology is not reportable in the US, making it difficult to understand whether recent levels are now reaching historic levels.

Egeberg and colleagues suggested that future research could study why physicians would choose to increase dosing – which as the study suggested, influenced cost- rather than switching treatments.

Women show significantly lower risk of first, recurrent life-threatening VTA events than men, while it is more pronounced in patients with NICM.

Dr. Amy Licis details the signs and symptoms of restless leg syndrome and how to identify it from other causes of sleep issues.

Rivaroxaban monotherapy was associated with a 38% lower risk of total cardiovascular and bleeding events.

The investigative team believed these associations were attributable to the chronic nature of the disease as well as negative associations with quality of life and sexual function.

Dr. Gadani often suggests patients eat smaller meals and do not eat too close to bedtime.

National prescribing cohort data suggest clinicians buck against the recommended use of the antidepressant.

A look into the top discussions on the management of obesity at the 2022 OMA Spring Meeting, from new agents to treating special populations.

Patients with anti-HBs also had higher APRI scores, FIB-4 scores, and liver stiffness values.

Combination treatment was equal to anti-VEGF monotherapy in functional and structural outcomes in the treatment of macular edema due to BRVO.

Vutrisiran is the first and only FDA-approved treatment that’s demonstrated reversal in neuropathy impairment with subcutaneous administration once every 3 months.

Data from the first human trial of the topical cream suggests a new approach to treating cutaneous warts in adults.

Dr. Akash B. Gadani said overall treatments for managing GERD are effective.

Dr. Aric Prather discusses the pandemic, his research, and his presentation from SLEEP 2022 "Sleep in the Time of COVID: An Update on How Sleep Affects the Immune System".

New data suggest race and ethnicity, income, education, rural vs urban residence, and living in a food desert all were independently associated with poor diet quality.